| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc. (KPTI) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. KPTI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 198.3K | $1.86M | - | |
| VP | 79.5K | $746.2K | - | |
| VP | 67.4K | $632.5K | - | |
| VP | 65.1K | $610.7K | - | |
| VP | 56.3K | $528.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2018 | Shacham Sharon79 | President &CSO | Sale+OE | 12,500 | $19.31 | $241,383.75 | -1.7% | |
| Sep 6, 2018 | Chione Ltd61 | 10% Owner | Sell | 164,800 | $21.05 | $3,468,729.92 | -1.1% | |
| Sep 4, 2018 | Chione Ltd61 | 10% Owner | Sell | 251,468 | $20.94 | $5,265,367.67 | -1.1% | |
| Aug 30, 2018 | Mirza Mansoor Raza79 | Director | Sale+OE | 2,500 | $21.00 | $52,500.00 | -100% | |
| Aug 29, 2018 | Mirza Mansoor Raza79 | Director | Sale+OE | 2,500 | $20.00 | $50,000.00 | -100% | |
| Aug 29, 2018 | Chione Ltd61 | 10% Owner | Sell | 214,026 | $19.52 | $4,178,055.55 | -1.3% | |
| Aug 20, 2018 | Shacham Sharon79 | President &CSO | Sale+OE | 10,000 | $17.46 | $174,568.00 | -1.9% | |
| Aug 20, 2018 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 10,000 | $17.46 | $174,568.00 | -1.9% | |
| Aug 10, 2018 | Chione Ltd61 | 10% Owner | Sell | 702 | $18.50 | $12,987.00 | - | |
| Aug 9, 2018 | Chione Ltd61 | 10% Owner | Sell | 80,876 | $18.52 | $1,498,077.48 | -0.3% |